LUCD,Lucid Diagnostics Inc. | Healthcare

Healthcare

LUCD

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Lucid Diagnostics Inc.LUCD

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company.

The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC).

It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test.

The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Latest News >

Research Alert: CFRA Maintains Buy Opinion On Shares Of Alphabet Inc.

Mar 18, 2025

11:10 AM EDT, 03/18/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: GOOGL announced its largest-ever acquisition, planning to acquire cloud security platform Wiz for $32B in cash, significantly above rumors of $23B a year earlier. The deal, expected to close in...

Research Alert: CFRA Maintains Buy Opinion On Shares Of Alphabet Inc.

Mar 18, 2025

11:05 AM EDT, 03/18/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: GOOG announced its largest-ever acquisition, planning to acquire cloud security platform Wiz for $32B in cash, significantly above rumors of $23B a year earlier. The deal, expected to close in...

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

Mar 18, 2025

11:07 AM EDT, 03/18/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.13% to 1,438.81 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which rose 6.8% and 3.7% respectively....

What's Going On With REE Automotive Stock Tuesday?

Mar 18, 2025

REE Automotive Ltd. ( REE ) shares are moving lower on Tuesday after the company announced the pricing of a $27 million registered direct offering. What To Know: The company is pricing 6,376,631 shares at $4.25 per share. REE intends to use the net proceeds for working capital and general corporate purposes. What Else: REE entered into a non-binding memorandum...